NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort

医学 肺癌 队列 内科学 肿瘤科 癌症研究
作者
Sarah Heynemann,Hui Yu,Leonid P. Churilov,Gareth Rivalland,Khashayer Asadi,Rebecca E. Mosher,Fred R. Hirsch,Chris J. Rivard,Paul L R Mitchell
出处
期刊:Clinical Lung Cancer [Elsevier BV]
卷期号:23 (2): e90-e98 被引量:9
标识
DOI:10.1016/j.cllc.2021.11.005
摘要

NaPi2b is a multi-transmembrane sodium-dependent phosphate transporter expressed at normal levels in several organs, including lung. High expression levels have been reported in various tumors including breast, thyroid, ovarian and non-small cell lung cancer. To date evaluation of NaPi2b expression has mostly been restricted to smaller lung cancer cohorts.Analyses were performed on archival formalin fixed paraffin embedded primary tumor specimens from patients who had undergone curative intent resection at an Australian tertiary hospital. Tissue microarrays were constructed and stained with the chimeric anti-NaPi2b antibody, MERS67. Semi-quantitative H-scores (range 0 - 300) were calculated for each core tissue sample (H-score = % tumor cells staining for NaPi2b multiplied by staining intensity). An overall average H-score was reported for each specimen, with a cut-off score of 50 considered positive.Of 438 cases, high NaPi2b expression was observed in 151 (34.5%) overall, high expression in 137 of 208 (65.9%) adenocarcinoma cases, and 5 of 179 (2.8%) squamous cases (P < .0001). High NaPi2b expression was associated with female sex, EGFR or KRAS mutation, and TTF1 positivity (adenocarcinoma cases only). High NaPi2b expression was associated with improved overall survival (median 54 vs. 35 months, P = .029).High NaPi2b expression was noted in a significant subset of adenocarcinoma cases, and in particular amongst those who were TTF1+, or exhibited EGFR or KRAS mutations. This agrees with earlier reports and highlights the significance that NaPi2b may have a role as a possible target for delivery of cytotoxic agents via antibody-drug conjugate models for some patients with lung adenocarcinoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
虚心灵煌完成签到,获得积分10
刚刚
刚刚
椰椰发布了新的文献求助10
1秒前
乐乐的应助被奇崽采纳,获得10
1秒前
niuniu完成签到 ,获得积分10
1秒前
L.YL发布了新的文献求助10
1秒前
Chenjunxian完成签到,获得积分10
2秒前
2秒前
现代水蓉完成签到,获得积分10
2秒前
开冲完成签到,获得积分10
3秒前
风流小鸡44完成签到,获得积分10
3秒前
秋风的应助被乐观的鞋子采纳,获得10
3秒前
霸气棉花糖完成签到,获得积分20
3秒前
xingxing发布了新的文献求助10
4秒前
曾欢完成签到,获得积分10
4秒前
葡萄狗发布了新的文献求助10
4秒前
斯文败类的应助被QQ采纳,获得10
4秒前
4秒前
5秒前
5秒前
5秒前
阿清咩完成签到 ,获得积分10
5秒前
5秒前
无限尔曼完成签到 ,获得积分10
5秒前
wangchi发布了新的文献求助10
6秒前
微笑的念梦完成签到,获得积分20
6秒前
6秒前
7秒前
7秒前
7秒前
輓楓完成签到,获得积分10
8秒前
molihuakai的应助被三笠采纳,获得10
8秒前
Wu完成签到 ,获得积分10
8秒前
Rinchemistry完成签到,获得积分10
9秒前
嘟嘟发布了新的文献求助10
9秒前
logic发布了新的文献求助10
10秒前
鱼游天下完成签到,获得积分10
10秒前
汤包发布了新的文献求助10
11秒前
风吹麦浪发布了新的文献求助10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183070
求助须知:如何正确求助?哪些是违规求助? 9572393
关于积分的说明 21824679
捐赠科研通 7779769
什么是DOI,文献DOI怎么找? 3433810
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480022